JPRN-UMIN000042422
Completed
未知
Verification of gastric symptom improvement effect in continuous intake of the lactic acid bacteria - Verification of gastric symptom improvement effect in continuous intake of the lactic acid bacteria
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- APO PLUS STATION CO., LTD.
- Enrollment
- 180
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Subjects undergoing medical institution consultation or treatment for diabetes, digestive disorders eating disorders, and stress\-related psychiatric disorders in the last 6 months 2\.Subjects who have received drug treatment for dyspepsia symptoms (antacids, secretory inhibitors, prokinetic agents, nonsteroidal anti\-inflammatory drugs, aspirin and antidepressants, etc.) in the last 6 months 3\.Subjects suspected of being positive for H. pylori or treated for H. pylori eradication 4\.Subjects experiencing severe heartburn or acid reflux on screening tests 5\.Subjects suspected of having diabetes, dyslipidemia, gastrointestinal disease and severe renal impairment on screening tests 6\.Subjects who have been regularly using drugs, quasi\-drugs, yogurt, lactic acid bacteria\-containing foods, health food nutritional function food, health food, and supplement for the past month or more 7\.Subjects who have been using lactic acid foods such as yogurt, lactic acid bacteria beverages, food for specified health use, nutritional functional food, health food, and supplements regularly for the past month or more 8\.Subjects with smoking habits 9\.Subjects whose normal drinking amount exceeds 1,000 mL (40 g in terms of alcohol) in terms of beer (5%) per day 10\.Subjects with food allergies 11\.Individuals who are pregnant individuals who plan or want to become pregnant during the study period individuals who are lactating 12\.Subjects with bleeding teeth or oral problems (stomatitis, etc.) during saliva test 13\.Subjects with large changes in lifestyle 14\.Subjects who travel, travel, or travel abroad for more than a week during the study period, or who may or may not 15\.Subjects who have participated in other clinical trial in the past one month, who have a plan to participate in other clinical trial during the test period 16\.Subjects who are judged as unsuitable for this clinical trial by the investigator for other reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study of the symptom improvement effect of gastric acid secretion inhibitors for refluxe esophagitis patients -Randomized controlled comparative test of vonoprazan and esomeprazoleReflux esophagitis patientsJPRN-UMIN000028502ational Hospital Organization National Kochi Hospital30
Completed
Not Applicable
Study of symptom improvement effect of gastric acid suppressive drugs in reflux esophagitis patients with type 2 diabetes mellitus -a randomized comparative study of vonoprazan vs esomeprazoleReflux esophagitis with type 2 diabetes mellitusJPRN-UMIN000026407Hachinohe City Hospital Department of Endocrinology and Diabetes40
Completed
Not Applicable
Study of symptom improvement effect of gastric acid suppressive drugs in reflux esophagitis patients -a randomized comparative study of vonoprazan vs esomeprazoleReflux esophagitisJPRN-UMIN000022166Department of Gastroenterology, Sapporo-kosei General Hospital40
Completed
Not Applicable
Evaluation of gastrointestinal symptoms and effectiveness of Rikkunshito for them after endoscopic submucosal dissection for gastric neoplasmsgastric cancerJPRN-UMIN000002302agasaki University Hospital40
Completed
Not Applicable
A study for efficacy on post-meal stomach discomfort by single intake of test foodHealthy individualsJPRN-UMIN000038258APO PLUS STATION CO., LTD.20